Photo of Dr Isabelle Leblanc

Dr Isabelle Leblanc

Telephone:

Email:

Location:

  • University College Hospital

GMC/GDC number:

6141927

Professional background

Dr Leblanc is a consultant anaesthetist at UCLH. She trained in Paris, France and worked as a consultant level for 20 years in Paris before relocating to London for personal reasons.

Her scope of practice includes anaesthesia in cardiovascular and thoracic, orthopaedic and major surgery, focusing on enhanced recovery after surgery and pain management including regional anaesthesia.

Specialties

Research interests

  • Perioperative medicine

Languages spoken

French

Publications

  • Concentrations of direct oral anticoagulants according to guidelines for the periprocedural management of low bleeding risk procedures. Godier A, Martin A-C, Lessire S, Mullier F, Leblanc I, Gouin-Thibault I. Anaesthesia, Crit Care Pain Med 2020;39:121-122.
  • Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients. Martin A-C, Lessire S, Leblanc I, Dincq A-S, Philip I, Gouin-Thibault I, Godier A. Clin Cardiol 2018;41:646–51.
  • Prospective analysis of serious cardiorespiratory events in children during ophthalmic artery chemotherapy for retinoblastoma under a deep standardized anesthesia. Nghe M-C, Godier A, Shaffii A, Leblanc I, Picard H, Blanc R, Lumbroso-Le Rouic L, Devys J-M. Paediatr Anaesth 2017;28:120–6.
  • Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. Godier A, Dincq A, Radu A, Leblanc I, Antona M, Vasse M, Golmard J. Eur Heart J 2017;38:2431–9.
  • Safety and efficiency of ultrasound-guided intermediate cervical plexus block for carotid surgery. Leblanc I, Chterev V, Rekik M, Boura B, Costanzo A, Bourel P, Combes M, Philip I. Anaesthesia, Crit Care Pain Med 2015;35:109–14.
  • Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations. Godier A, Martin A-C, Leblanc I, Mazoyer E, Horellou M-H, Ibrahim F, Flaujac C, Golmard J-L, Rosencher N, Gouin-Thibault I. Thromb Res 2015;136:763–8.
  • Management of Direct Oral Anticoagulants in the Perioperative Setting. Untereiner O, Seince P, Chterev V, Leblanc I, Berroëta, Clarisse, Bourel, Patrick, Philip I. J Cardiothorac Vasc Anesth 2015;29:741–8.
  • Perioperative challenges of atrial fibrillation. Philip I, Berroëta C, Leblanc I. Curr Opin Anaesthesiol 2014;27:344-52
  • Futile D-dimer testing in hospitalized patients--description, interpretation, improvements. Girard P, Suresh R, Cosserat J, Czitrom D, Guillou J-L Le, Leblanc I, Strauss C, Stern J-B. Thromb Haemost 2008;100:1209–11.
  • Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates. Bricon T Le, Leblanc I, Benlakehal M, Gay-Bellile C, Erlich D, Boudaoud S. Clin Chem Lab Med 2005;43:953–7.
  • Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients. Ethuin F, Boudaoud S, Leblanc I, Troje C, Marie O, Levron J-C, Moing J-P Le, Assoune P, Eurin B, Jacob L. Intensive Care Med 2003;29:1916–20.
  • Reversal of intraoperative myocardial ischemia with a hemoglobin-based oxygen carrier. Niquille M, Touzet M, Leblanc I, Baron JF. Anesthesiology 2000;92:882–5.
  • Administration of desmopressin in brain-dead donors does not modify renal function in kidney recipients. Ourahma S, Guesde R, Leblanc I, Riou B, Goarin JP, Bitker MO, Coriat P. Transplant Proc 1998;30:2844.
  • Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Guesde R, Barrou B, Leblanc I, Ourahma S, Goarin JP, Coriat P, Riou B. The Lancet 1998;352:1178-81
  • Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. The lancet 1996;348;1620-2